Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025
Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, has scheduled the release of its second quarter 2025 financial results for Wednesday, August 6th, 2025. The company will host a conference call at 8:30 A.M. (EST) to discuss the results.
Perrigo is a pure-play self-care company specializing in over-the-counter (OTC) health and wellness solutions in North America and Europe. Their business model combines store brand private label offerings with leading brands including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
Perrigo (NYSE: PRGO), un importante fornitore di Prodotti per l'Auto-Cura del Consumatore, ha programmato la pubblicazione dei suoi risultati finanziari del secondo trimestre 2025 per mercoledì 6 agosto 2025. L'azienda terrà una conference call alle 8:30 A.M. (EST) per discutere i risultati.
Perrigo è un'azienda specializzata esclusivamente nell'auto-cura, focalizzata su soluzioni per la salute e il benessere da banco (OTC) in Nord America ed Europa. Il loro modello di business combina offerte di marchi privati con marchi leader tra cui Opill®, Mederma®, Compeed®, EllaOne® e Jungle Formula®.
Perrigo (NYSE: PRGO), un proveedor líder de Productos de Autocuidado para el Consumidor, ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el miércoles 6 de agosto de 2025. La compañía realizará una llamada conferencia a las 8:30 A.M. (EST) para discutir los resultados.
Perrigo es una empresa especializada exclusivamente en autocuidado, enfocada en soluciones de salud y bienestar de venta libre (OTC) en Norteamérica y Europa. Su modelo de negocio combina marcas privadas de tienda con marcas líderes como Opill®, Mederma®, Compeed®, EllaOne® y Jungle Formula®.
Perrigo (NYSE: PRGO)는 소비자 자가 관리 제품의 선도적인 제공업체로서, 2025년 2분기 재무 실적을 2025년 8월 6일 수요일에 발표할 예정입니다. 회사는 동부 표준시 기준 오전 8시 30분에 실적 관련 컨퍼런스 콜을 진행할 예정입니다.
Perrigo는 북미와 유럽에서 일반의약품(OTC) 건강 및 웰니스 솔루션에 특화된 순수 자가 관리 회사입니다. 이들의 비즈니스 모델은 Opill®, Mederma®, Compeed®, EllaOne®, Jungle Formula® 등 주요 브랜드와 매장 브랜드 사설 상표 제품을 결합하고 있습니다.
Perrigo (NYSE : PRGO), un fournisseur majeur de produits d'autosoins grand public, a prévu la publication de ses résultats financiers du deuxième trimestre 2025 pour le mercredi 6 août 2025. La société tiendra une conférence téléphonique à 8h30 (EST) pour discuter des résultats.
Perrigo est une entreprise spécialisée exclusivement dans l'autosoins, proposant des solutions de santé et de bien-être en vente libre (OTC) en Amérique du Nord et en Europe. Leur modèle commercial combine des marques de distributeur avec des marques leaders telles que Opill®, Mederma®, Compeed®, EllaOne® et Jungle Formula®.
Perrigo (NYSE: PRGO), ein führender Anbieter von Consumer Self-Care-Produkten, hat die Veröffentlichung seiner Finanzergebnisse für das zweite Quartal 2025 für Mittwoch, den 6. August 2025, geplant. Das Unternehmen wird um 8:30 Uhr (EST) eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Perrigo ist ein reines Self-Care-Unternehmen, das sich auf rezeptfreie (OTC) Gesundheits- und Wellnesslösungen in Nordamerika und Europa spezialisiert hat. Ihr Geschäftsmodell kombiniert Handelsmarken mit führenden Marken wie Opill®, Mederma®, Compeed®, EllaOne® und Jungle Formula®.
- None.
- None.
The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 45051. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, August 6, until midnight Wednesday, August 13, 2025. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 45051#.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.
Perrigo Contact
Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com
Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-second-quarter-2025-financial-results-on-august-6-2025-302511250.html
SOURCE Perrigo Company plc
FAQ
When will Perrigo (PRGO) release Q2 2025 earnings?
How can investors access Perrigo's Q2 2025 earnings call?
What are Perrigo's main consumer brands?
When will the replay of Perrigo's Q2 2025 earnings call be available?
